Yue Jin-feng, Qiao Guan-hua, Liu Ni, Nan Fa-jun, Gao Zhao-bing
CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Chinese Academy of Sciences, Shanghai 201203, China.
The National Center for Drug Screening, Shanghai Institute of Materia Medica, State Key Laboratory of Drug Research, Chinese Academy of Sciences, Shanghai 201203, China.
Acta Pharmacol Sin. 2016 Jan;37(1):105-10. doi: 10.1038/aps.2015.142.
To establish an improved, high-throughput screening techniques for identifying novel KCNQ2 channel activators.
KCNQ2 channels were stably expressed in CHO cells (KCNQ2 cells). Thallium flux assay was used for primary screening, and 384-well automated patch-clamp IonWorks Barracuda was used for hit validation. Two validated activators were characterized using a conventional patch-clamp recording technique.
From a collection of 80 000 compounds, the primary screening revealed a total of 565 compounds that potentiated the fluorescence signals in thallium flux assay by more than 150%. When the 565 hits were examined in IonWorks Barracuda, 38 compounds significantly enhanced the outward currents recorded in KCNQ2 cells, and were confirmed as KCNQ2 activators. In the conventional patch-clamp recordings, two validated activators ZG1732 and ZG2083 enhanced KCNQ2 currents with EC50 values of 1.04±0.18 μmol/L and 1.37±0.06 μmol/L, respectively.
The combination of thallium flux assay and IonWorks Barracuda assay is an efficient high-throughput screening (HTS) route for discovering KCNQ2 activators.
建立一种改进的高通量筛选技术,用于鉴定新型KCNQ2通道激活剂。
KCNQ2通道在CHO细胞(KCNQ2细胞)中稳定表达。采用铊通量测定法进行初步筛选,使用384孔自动膜片钳IonWorks Barracuda进行命中验证。使用传统膜片钳记录技术对两种经过验证的激活剂进行表征。
从80000种化合物库中,初步筛选共发现565种化合物在铊通量测定中使荧光信号增强超过150%。当在IonWorks Barracuda中检测这565个命中化合物时,38种化合物显著增强了在KCNQ2细胞中记录的外向电流,并被确认为KCNQ2激活剂。在传统膜片钳记录中,两种经过验证的激活剂ZG1732和ZG2083增强KCNQ2电流,其半数有效浓度(EC50)值分别为1.04±0.18μmol/L和1.37±0.06μmol/L。
铊通量测定法和IonWorks Barracuda测定法的结合是发现KCNQ2激活剂的一种高效高通量筛选(HTS)途径。